Yahoo Web Search

Search results

1. • 

     Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration

     Benzinga via Yahoo Finance· 7 hours ago

     After topping expectations with first quarter revenue and adjusted earnings last week, Merck & Co...

2. • 

     Merck stock target raised on strong Q1 results By Investing.com

     Investing.com· 6 days ago

     On Friday, Wells Fargo adjusted its outlook on shares of pharmaceutical giant Merck & Co., Inc....

3. • 

     Is Merck Stock Fully Valued At $130?

     Forbes· 2 days ago

     Merck (NYSE: MRK) recently reported its Q1 results, with revenues and earnings exceeding our estimates. The growth was primarily driven by higher sales...

4. • 

     Cerevance receives milestone payment under Alzheimer's collaboration with Merck

     Seeking Alpha· 10 hours ago

     Privately held Cerevance receives milestone payment from Merck for Alzheimer's research...

5. • Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $143.00

     ETF DAILY NEWS· 4 days ago

     Merck & Co., Inc. (NYSE:MRK – Free Report) had its target price boosted by Truist Financial from $142.00 to $143.00 in a research report released on Friday ...

6. • 

     Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com

     Investing.com· 1 day ago

     Merck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...

7. • 

     Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript

     Insider Monkey via Yahoo Finance· 3 days ago

     Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...

8. • 

     Pfizer's Stock Is a Buy. Here Are Six Reasons Why.

     Motley Fool via Yahoo Finance· 17 hours ago

     The Motley Fool has positions in and recommends Bristol Myers Squibb, Merck, and Pfizer. The Motley Fool has a disclosure policy. Pfizer's Stock Is a Buy...

9. • 

     3 Investing Pros Lay Out Their Dividend Strategies—and Stock Picks

     Barrons.com· 20 hours ago

     But many dividend stocks have been trailing the market. The S&P...Santoro, and “the ability to...

10. • 

      What’s going on with the ImmunityBio (IBRX) stock price?

      Invezz· 3 days ago

      ImmunityBio (NASDAQ: IBRX) stock price has gone parabolic as investors cheer the recent approval of...